In the complex and rapidly evolving field of brain tumor treatment, Dr. James Snyder, DO, stands out as a pioneering force. Based at the renowned Henry Ford Hermelin Brain Tumor Center in Detroit, Michigan, Dr. Snyder has dedicated his career to bridging the gap between cutting-edge technology and compassionate, patient-centered advocacy.

Dr. Snyder is a board-certified neurologist and fellowship-trained neuro-oncologist who specializes in treating both primary and metastatic brain tumors. His clinical philosophy is rooted in precision medicine—the idea that treatment should be tailored to the specific genetic and biological makeup of a tumor rather than its location alone. By utilizing advanced tools like genomics and liquid biopsies, Dr. Snyder works to identify the most effective therapies for his patients, often before traditional symptoms even escalate.

Beyond the exam room, Dr. Snyder serves as a leader in healthcare innovation. As the Associate Chief Medical Officer for Henry Ford Innovations, he evaluates how emerging technologies like Artificial Intelligence (AI) and computer vision can be integrated into real-world medical practice. His research interests are notably forward-thinking, focusing on:

• Access to Care: Reducing barriers for patients in underserved areas through virtual tumor boards and telehealth platforms.
• Bioinformatics & Radiomics: Leveraging data-driven insights to improve diagnostic accuracy and predict treatment responses.
• Clinical Trials: Providing patients with early access to the next generation of breakthroughs for conditions like glioblastoma and meningioma.

What truly defines Dr. Snyder’s practice is his role as a patient advocate. He is a regular participant in national advocacy efforts, such as the Head to the Hill events in Washington, D.C., where he helps patients  https://www.jamesbsnydermd.com/ lobby for increased federal funding for brain cancer research.

Patient reviews consistently highlight his ability to translate complex medical information into understandable language. Whether he is discussing “scanxiety” or detailing the intricacies of a tumor board’s decision, Dr. Snyder is recognized for his “precision care” that balances high-tech solutions with a warm, empathetic presence.

A graduate of Michigan State University College of Osteopathic Medicine, Dr. Snyder completed his neuro-oncology fellowship at Henry Ford in 2016. Today, he is an active member of elite organizations, including the Society for Neuro-Oncology and the National Cancer Institute, ensuring his patients benefit from a global network of expertise.

Would you like to explore Dr. Snyder’s latest research on liquid biopsies or see how to schedule a virtual consultation?